Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fernandez, Jasmine
PIKture-01, NCT06239467: First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer	Recruiting	1	150	Europe, US, RoW	OKI-219, Fulvestrant, Trastuzumab	OnKure, Inc.	Advanced Cancer, Breast Cancer	06/26	08/27